| Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression L Vanhersecke, M Brunet, JP Guégan, C Rey, A Bougouin, S Cousin, ... Nature Cancer 2 (8), 794-802, 2021 | 216 | 2021 |
| Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon CL Sofeu, J Warszawski, F Ateba Ndongo, IC Penda, S Tetang Ndiang, ... PloS one 9 (4), e93554, 2014 | 39 | 2014 |
| Conditional copula models for correlated survival endpoints: Individual patient data meta-analysis of randomized controlled trials T Emura, CL Sofeu, V Rondeau Statistical Methods in Medical Research 30 (12), 2634-2650, 2021 | 29 | 2021 |
| Virologic response to early antiretroviral therapy in HIV-infected infants: evaluation after 2 years of treatment in the Pediacam study, Cameroon FA Ndongo, G Texier, CI Penda, MC Tejiokem, ST Ndiang, JA Ndongo, ... The Pediatric infectious disease journal 37 (1), 78-84, 2018 | 27 | 2018 |
| Improving systematic rabies surveillance in Cameroon: a pilot initiative and results for 2014-2016 CL Sofeu, A Broban, A Njifou Njimah, J Blaise Momo, SA Sadeuh-Mba, ... PLoS neglected tropical diseases 12 (9), e0006597, 2018 | 22 | 2018 |
| Standardized pathology screening of mature tertiary lymphoid structures in cancers L Vanhersecke, A Bougouin, A Crombé, M Brunet, C Sofeu, M Parrens, ... Laboratory Investigation 103 (5), 100063, 2023 | 14 | 2023 |
| A joint frailty‐copula model for meta‐analytic validation of failure time surrogate endpoints in clinical trials CL Sofeu, T Emura, V Rondeau Biometrical Journal 63 (2), 423-446, 2021 | 14 | 2021 |
| Early treated HIV-infected children remain at risk of growth retardation during the first five years of life: Results from the ANRS-PEDIACAM cohort in Cameroon CL Sofeu, MC Tejiokem, CI Penda, C Protopopescu, F Ateba Ndongo, ... PLoS One 14 (7), e0219960, 2019 | 14 | 2019 |
| One‐step validation method for surrogate endpoints using data from multiple randomized cancer clinical trials with failure‐time endpoints CL Sofeu, T Emura, V Rondeau Statistics in medicine 38 (16), 2928-2942, 2019 | 13 | 2019 |
| Time to next treatment or death as a candidate surrogate endpoint for overall survival in advanced melanoma patients treated with immune checkpoint inhibitors: an insight from … S Branchoux, CL Sofeu, AF Gaudin, M Kurt, A Moshyk, A Italiano, ... ESMO open 7 (1), 100340, 2022 | 12 | 2022 |
| Frailtypack: general frailty models: shared, joint and nested frailty models with prediction; evaluation of failure-time surrogate endpoints; 2019 V Rondeau, JR Gonzalez, Y Mazroui, A Mauguen, A Diakite, A Laurent, ... R package version 3 (3), 2019 | 11 | 2019 |
| Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with … AKW Kfutwah, PAT Ngoupo, CL Sofeu, FA Ndongo, G Guemkam, ... BMC infectious diseases 17, 1-10, 2017 | 10 | 2017 |
| Package ‘frailtypack’ V Rondeau, JR Gonzalez, A Yassin Mazroui, AD Mauguen, A Laurent, ... General frailty models: shared, joint and nested frailty models with prediction, 2013 | 9 | 2013 |
| Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants? F Ateba Ndongo, J Warszawski, G Texier, I Penda, S Tetang Ndiang, ... BMC pediatrics 15, 1-9, 2015 | 7 | 2015 |
| How to use frailtypack for validating failure-time surrogate endpoints using individual patient data from meta-analyses of randomized controlled trials CL Sofeu, V Rondeau PloS one 15 (1), e0228098, 2020 | 5 | 2020 |
| Low rate of early vertical transmission of HIV supports the feasibility of effective implementation of the national PMTCT guidelines in routine practice of referral hospitals … CI Penda, MC Tejiokem, CL Sofeu, ST Ndiang, F Ateba Ndongo, ... Paediatrics and International Child Health 39 (3), 208-215, 2019 | 5 | 2019 |
| Practices of Care to HIV-Infected Children: Current Situation in Cameroon CI Penda, FA Ndongo, ACZK Bissek, MC Téjiokem, C Sofeu, ... Clinical Medicine Insights: Pediatrics 13, 1179556519846110, 2019 | 2 | 2019 |
| Long-term outcomes of early initiated antiretroviral therapy in sub-Saharan children: a Cameroonian cohort study (ANRS-12140 Pediacam study, 2008–2013, Cameroon) FA Ndongo, MC Tejiokem, CI Penda, ST Ndiang, JA Ndongo, ... BMC pediatrics 21, 1-11, 2021 | 1 | 2021 |
| Exploratory analyses of surrogate endpoints in metastatic non-small cell lung cancer F Bouteiller, S Cousin, C Sofeu, G Perrocheau, R Gervais, M Perol, ... Revue d'Épidémiologie et de Santé Publique 69, S35, 2021 | | 2021 |
| PCN29 Time to Next Treatment As a Candidate Surrogate Endpoint for Overall Survival in Previously Untreated Advanced Melanoma Patients Treated with Immune-Checkpoint Inhibitors S Branchoux, CL Sofeu, AF Gaudin, M Kurt, A Moshyk, A Italiano, ... Value in Health 23, S426, 2020 | | 2020 |
